Articles by Pharma IQ News

The world economy will grow by 3.3 this year, and by 3.7 per cent in 2014: still below trend. In the developed world, divergence continues; the US will grow just over 2 per cent in each year, while the Euro Area remains in recession and will grow only about 1 per cent next year. Unemployment remains very high in most countries, and at depression-era rates in some peripheral Euro Area countries....Full Article »

The European Medicines Agency (EMA) has published the final advice from the advisory groups that have been set up to inform the EMA in drafting its policy on proactive access to clinical-trial data. The EMA has committed to the proactive publication of data from clinical trials supporting the authorisation of medicines once the marketing-authorisation process has ended, which the EMA does not...Full Article »

The European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide documents as part of two access-to-documents requests until a final ruling is given by the Court. These interim rulings were made as part of court cases brought by two pharmaceutical companies, AbbVie and InterMune. The companies are challenging the Agency’s decisions to grant...Full Article »

One in every two top pharma company managers expects share of revenues coming from emerging markets to exceed 30% by 2018 Local idiosyncrasies make it essential to have bespoke approaches Do we need to redefine the so-called emerging markets as the gulf between the BRICMT markets and Africa continues to grow? London, 26 th March 2013 - International pharmaceutical companies expect a significant...Full Article »

Whoever said it’s what's in the inside that counts was quite frankly lying. Given that you invest so much time, money and resources on our pharmaceutical products - don't you want to ensure the packaging in which it’s promoted is as good, if not better than what is inside? Successful commercialisation is the end point which every biopharma company strives for, but quite often...Full Article »

- Comment from Intellectual Property Specialists Marks & Clerk on 2012 patent filing statistics released by European Patent Office - Statistics from the Annual Report of European Patent Office (EPO), released today, reveal that patent filings at the EPO reached record levels in 2012. The figures published today also detail the countries which European patent applications originated from last...Full Article »

With increasing recognition of the need to attract, foster and retain Millenial, or Generation Y, talent in the pharmaceutical industry [1] , it is important to understand what motivates the up-and-coming senior management class of the future. New research from the iOpener Institute for People and Performance, which analysed responses from over 18,000 professionals, has shown the digital...Full Article »

Almac today announces the successful inspection of its new US Commercial Packaging operations located in Audubon, PA by the Food and Drug Administration (FDA). The inspection took place on the 9th and 10th January 2013 from which the regulatory body concluded that the Pennsylvania based site is fully compliant with Good Manufacturing Practices, with no 483 issued. Commenting on the inspection,...Full Article »

London, United Kingdom, November 26 th 2012 – A new study by EPG Health Media (Europe) Ltd provides insight into the views and behaviour of healthcare professionals (HCPs) in Europe on the topic of Continuing Medical Education (CME).  Launched at the 5 th Annual European Continuing Medical Education Forum in London earlier this month, the report provides data to support on-going...Full Article »

Ahead of the China Bio/Pharmaceutical and Clinical Supply Chain Convention 2013 to be held on the 16-17 January 2013 at the Renaissance Beijing Capital Hotel in Beijing, Pharma IQ interviewed Ma Jingdong, Medical Director at Mundipharma China on what he thinks CROs and pharmaceutical companies can do to improve their relationship to achieve better clinical trial results. Mr Ma stressed that both...Full Article »

World growth is expected to remain below trend at 3.1 per cent in 2012 and 3.4 per cent in 2013. The Euro Area is forecast to contract by 0.5 per cent this year and grow only marginally next year with unemployment reaching ‘depression-era’ rates in some periphery economies. The US is likely to grow by 2 per cent in each year. Growth in Brazil, Russia, India and China will be below...Full Article »